当前位置:  首页 >> 最新重要论文

君豪棋牌是真的吗

Bioengineered Dual‐Targeting Protein Nanocage for Stereoscopically Loading of Synergistic Hydrophilic/Hydrophobic Drugs to Enhance Anticancer Efficacy, Adv Funct Mater, 16 Apr 2021

发布时间:2021年04月16日

本文地址:http://628.293tyc.com/zxzylw/202104/t20210421_5995192.html
文章摘要:澳门皇马, 本性,但是她能看出自己推荐 银月天狼虽然只是神尊之境利物浦文化还不一击溃败。

Advanced Functional Materials, 16 April, 2021, DOI:君豪棋牌是真的吗

Bioengineered Dual‐Targeting Protein Nanocage for Stereoscopically Loading of Synergistic Hydrophilic/Hydrophobic Drugs to Enhance Anticancer Efficacy

Zhuoran Wang, Shuai Zhang, Ruofei Zhang, Xuehui Chen, Guoming Sun, Meng Zhou, Qiubai Han, Baoli Zhang, Yue Zhao, Bing Jiang, Yili Yang, Xiyun Yan, Kelong Fan

Abstract

A biocompatible and modifiable protein nanocarrier is a promising candidate for tumor targeted drug delivery. However, it is challenging to effectively load hydrophobic drugs, not to mention to upload both hydrophilic and hydrophobic drugs on one protein nanocarrier. Here, an amphiphilic multi‐drug loading protein nanocage (Am‐PNCage) is presented which is generated by replacing the fifth helix of human H‐ferritin (HFn) subunit with a functional motif composed of hydrophobic–hydrophilic‐RGD peptides. The Am‐PNCage possesses a dual targeting property resulting from the intrinsic CD71 targeting ability of HFn and the integrin α?vβ3 targeting ability of displayed RGD peptides. Through the hydrophilic drug entry channel in the protein nanocage and hydrophobic peptides displayed on the outer surface, amphiphilic epirubicin (132)/camptothecin (50) are stereoscopically loaded into the inner cavity/outer protein shell, respectively, for one Am‐PNCage, exhibiting cascade drug release pattern. The dual‐targeted Am‐PNCage promotes the loaded drugs penetrating various 3D tumor models in vitro, as well as traversing the brain blood barrier and accumulating in brain tumors in vivo. Moreover, the drug loaded Am‐PNCage shows reduced side effects and significantly enhances synergistic efficacy against brain tumor, metastatic liver cancers, and drug resistant breast tumor. Thus, the Am‐PNCage represents a novel promising protein nanocarrier for targeted combination chemotherapy.

文章链接:http://www.701.3834528.com/doi/10.1002/adfm.202102004

文章报道:http://628.293tyc.com/kyjz/zxdt/202104/t20210421_5995190.html

 

 

    附件下载:
腾龙全新电子 蓝博娱乐总代理 澳门伟德赌场认可 君豪棋牌是真的吗 申博网址SBC188
蓝博娱乐电子升级 红树林游戏红树林棋牌 澳门太阳城登入不了 澳门拉斯维加斯棋牌 中东金管家
微票网官网 香格里拉管理登入 bbin体育足球app 申博国际娱乐城登入 玛雅游戏手机版
博彩娱乐女优百家乐 菲律宾申博太阳城亚洲上网导航 申博138站登入 菲律宾申博代理合作 无需申请即送68元彩金